The prevalence of electronic products has made eye diseases more and more common in our lives. Common eye diseases include glaucoma, cataracts, mydriasis, dry eye, sty, bacterial conjunctivitis, etc. The common drugs used to treat eye diseases are mostly eye drops. Therefore, eye drop bottles are also widely used in common ophthalmology drugs.
Data show that from 2013 to 2017, the size of my country's ophthalmology market increased from 46.7 billion yuan to 86.6 billion yuan, with an average annual compound growth rate of 16.7%. With the increase in the incidence of ophthalmology, the upgrading of ophthalmic treatment technology, and the improvement of patient diagnosis and treatment awareness, the scale of my country's ophthalmology market is expected to continue to grow at a growth rate of about 14% between 2018 and 2022.
There are tablets for the treatment of ophthalmic diseases, such as: latanoprost, diclofinamide, zhangyanming tablets, scopolamine, dehydrocholic acid tablets, voriting tablets, etc.; there are also cream drugs, such as dementia Eye ointment, tetracycline ointment, yellow mercury oxide ointment, etc., among which there are many kinds of eye drops, such as timolol, clonidine, chlortetracycline, rifampicin, chloramphenicol, sodium sulfacetamide, Shaoyanning, Xiaolaiwei, sodium hydroxymethylcellulose, phthalazin, phthalazin, etc., almost every kind of eye disease treatment medicine has eye drops. Therefore, in the ophthalmic medicine packaging, eye drops Bottles occupy a large market.
With the increase in ophthalmological diseases, the market demand for ophthalmic drugs such as eye drops is also increasing. On the whole, the application of eye drop bottles in common ophthalmic drugs packaging will become more common.
